Innovative Cancer Therapies

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 233

Special Issue Editors


E-Mail Website
Guest Editor
Department of Radiation Oncology, Peking University Third Hospital, Beijing, China
Interests: radiotherapy; immunotherapy; brachytherapy; translational research; comprehensive cancer treatment

E-Mail Website
Guest Editor
Hubei Cancer Hospital, Wuhan, China
Interests: radiotherapy; chemotherapy

Special Issue Information

Dear Colleagues,

This Special Issue will be centered around the theme of "Innovative Cancer Therapies", aiming to showcase groundbreaking research and advancements in the field of oncology. Given your exceptional expertise and pioneering work in this area, your insights would be instrumental in making this Special Issue a resounding success.

We are seeking contributions that highlight novel approaches, cutting-edge technologies, and transformative ideas in cancer treatments. Your work has consistently demonstrated excellence in these aspects, and we believe your contribution would greatly enrich the collective knowledge of our readers and fellow researchers.

Your valuable contribution to this Special Issue would be an honor for us and a significant addition to the scientific discourse on innovative cancer therapies. We eagerly await your response and look forward to the possibility of collaborating with you.

Dr. Suqing Tian
Dr. Guang Han
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • radiotherapy
  • immunotherapy
  • brachytherapy
  • translational research
  • comprehensive cancer treatment

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop